CORV News and Press, Correvio Pharma Corp. From 08/01/19

NASDAQ: CORV   TSX: CORV VANCOUVER , Aug. 1, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that it has undertaken an overnight marketed underwritten public o...

NASDAQ: CORV   TSX: CORV NDA Seeks Approval for Brinavess for the Treatment of Recent Onset Atrial Fibrillation; PDUFA Date Set for December 24, 2019 Company Also Reports Certain Preliminary Financial Results for Second Quarter 2019 VANCOUVER , July 25, 2019 /PRNew...

Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation Canada NewsWire VANCOUVER, June 24, 2019 NASDAQ: CORV   TSX: CORV VANCOUVER , June 24, 2019 /CNW/ - Correvio Pharm...

Correvio Announces Voting Results Canada NewsWire VANCOUVER, June 18, 2019 NASDAQ: CORV  TSX: CORV VANCOUVER , June 18, 2019 /CNW/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital ...

Correvio Pharma Corp. (CORV) Q1 2019 Earnings Conference Call May 07, 2019 08:30 AM ET Company Participants Mark Corrigan - CEO Justin Renz - President and CFO Conference Call Participants Dewey Steadman - Canaccord Presentation Operator Good morning, ladies and gen...

The following slide deck was published by Correvio Pharma Corp. in conjunction with their 2019 Q1 earnings Read more ...

Correvio Pharma (NASDAQ: CORV ): Q1 GAAP EPS of -$0.23 misses by $0.03 . More news on: Correvio Pharma Corp., Earnings news and commentary, Healthcare stocks news, , Read more ...

Mark H.N. Corrigan , MD Commences Role as CEO, effective March 14, 2019 Company on Track to Resubmit Brinavess NDA in Q2 2019 Management to Host Conference Call and Webcast Today, May 8, 2019 at 8:30 a.m. Eastern ( 5:30 a.m. Pacific) NASDAQ: CORV  TSX: CORV VANCO...

Conference Call Scheduled for Wednesday, May 8, 2019 at 8:30 a.m. Eastern ( 5:30 a.m. Pacific) NASDAQ: CORV  TSX: CORV VANCOUVER , May 1, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV / TSX: CORV), a specialty pharmaceutical company focused on commercializing ...

Play Video Day one of the Bloom Burton & Co. Healthcare Investor Conference (BBHIC) has officially wrapped up and the start of the annual show proved to be another roaring success.  Now in its eighth ye...